Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
Exploration of the pharmacodynamic profile of Acelarin, a novel ProTide drug, in an in vitro model of ovarian cancer
Item metadata
dc.contributor.advisor | Harrison, David James | |
dc.contributor.author | Bré, Jennifer | |
dc.coverage.spatial | 238 p. | en_US |
dc.date.accessioned | 2019-10-25T11:46:10Z | |
dc.date.available | 2019-10-25T11:46:10Z | |
dc.date.issued | 2019-06-28 | |
dc.identifier.uri | https://hdl.handle.net/10023/18773 | |
dc.language.iso | en | en_US |
dc.publisher | University of St Andrews | |
dc.subject.lcc | RM301.57B8 | |
dc.title | Exploration of the pharmacodynamic profile of Acelarin, a novel ProTide drug, in an in vitro model of ovarian cancer | en_US |
dc.type | Thesis | en_US |
dc.contributor.sponsor | NHS Lothian | en_US |
dc.contributor.sponsor | NuCana PLC | en_US |
dc.type.qualificationlevel | Doctoral | en_US |
dc.type.qualificationname | PhD Doctor of Philosophy | en_US |
dc.publisher.institution | The University of St Andrews | en_US |
dc.rights.embargodate | 2022-05-31 | |
dc.rights.embargoreason | Thesis restricted in accordance with University regulations. Print and electronic copy restricted until 31st May 2022 | en |
dc.identifier.doi | https://doi.org/10.17630/10023-18773 |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.